Veritable’s Cabaletta Bio CABA Stock Holding History

Veritable’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-37,245	Closed	-$481K	–	114
2023 Q2	$481K	Hold	37,245	–	–	0.01%	557
2023 Q1	$308K	Hold	37,245	–	–	0.01%	679
2022 Q4	$345K	Hold	37,245	–	–	0.01%	623
2022 Q3	$24K	Hold	37,245	–	–	﹤0.01%	787
2022 Q2	$39K	Hold	37,245	–	–	﹤0.01%	879
2022 Q1	$76K	Buy	37,245 +26,745	+255%	+$69.9K	﹤0.01%	893
2021 Q4	$40K	Hold	10,500	–	–	﹤0.01%	903
2021 Q3	$128K	Hold	10,500	–	–	﹤0.01%	861
2021 Q2	$90K	Hold	10,500	–	–	﹤0.01%	854
2021 Q1	$117K	Hold	10,500	–	–	﹤0.01%	818
2020 Q4	$131K	Hold	10,500	–	–	﹤0.01%	770
2020 Q3	$114K	Hold	10,500	–	–	﹤0.01%	719
2020 Q2	$117K	Buy	+10,500	New	+$80.4K	﹤0.01%	740

Other funds holding CABA

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Veritable's CABA Position: Q3 2023 in Review

Veritable sold out of Cabaletta Bio (CABA) in Q3 2023, closing a stake of 37,245 shares — an estimated $481K sold.

Veritable first reported a position in CABA in Q2 2020 and held it in 13 quarters. The position peaked at $481K in Q2 2023. 97 funds tracked by Wall St. Rank hold CABA as of Q3 2023.

Veritable reported no remaining Cabaletta Bio position as of Q3 2023 after selling out during the quarter.
Veritable sold 37,245 Cabaletta Bio shares in Q3 2023, an estimated $481K.
Veritable first reported a position in Cabaletta Bio in Q2 2020 and held it in 13 quarters.
Veritable's Cabaletta Bio position peaked at $481K in Q2 2023.
97 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2023.

Based on Veritable's 13F filing for Q3 2023.